NINEVEH MCINTOSH: Open Payments
NPI 1730430893 · ST. JOHNS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$590 in 30 payments from 12 companies in 2025. Trend: 2023 $552 · 2024 $665 · 2025 $590
Food & beverage: $590
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $131 |
| PFIZER INC. | 5 | $105 |
| Novo Nordisk Inc | 5 | $91 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| Amgen Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
Products named: VRAYLAR, INJECTAFER, Wegovy, REXULTI, QULIPTA, NURTEC ODT, Ozempic, ELIQUIS.
Industry payments across FL — which companies pay providers there.
